AndroGel

perrigo

Perrigo Confirms FDA Approval For Testosterone Gel 1%

Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo’s NDA included a bioequivalence study that compared its product to AbbVie’s AndroGel 1%.

WWJ Newsradio 950–02/06/2013

Follow

Get every new post delivered to your Inbox.

Join 1,975 other followers